Shows greater disease control in psoriatic arthritis with ixekizumab and tirzepatide, implying improved treatment options for adults with obesity.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Merola et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: